Global Immunoglobulins Market Report 2024

Immunoglobulins Global Market Report 2024 – By Product (IGG, IGA, IGM, IGE, IGD. ), By Mode Of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Immunoglobulins Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Immunoglobulins Market Definition And Segments

Immunoglobins refer to glycoproteins, often known as antibodies, that are created by plasma cells (white blood cells). They play a crucial role in the immune response by selectively identifying and attaching to specific antigens, such as viruses or bacteria, and assisting in their eradication.

The main types of products in immunoglobulins are IGG, IGA, IGM, IGE, and IGD. Immunoglobulin G (IGG) is the primary stimulator of humoral immunity in extracellular fluids such as blood, lymph, and saliva. The immunoglobulins are delivered using the intravenous mode of delivery, subcutaneous mode of delivery and are used in hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), others.

The immunoglobulins market covered in this report is segmented –

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode of Delivery, Subcutaneous Mode of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

The immunoglobulins market size has grown strongly in recent years. It will grow from $17.49 billion in 2023 to $19.07 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases.

The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $28.3 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes.

Growing Geriatric Population Fuels Demand For Immunoglobulins Market

The increasing geriatric population drives the growth of the immunoglobulins market. The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body's ability to produce antibodies that protect it from bacteria, viruses, and allergies. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins market during the forecast period.

Increasing Healthcare Expenditures Are Anticipated To Boost The Immunoglobulins Market

The increasing healthcare expenditure is expected to boost the growth of the immunoglobulins market going forward. Healthcare expenditure refers to the total amount of money spent by individuals, organizations, and governments on healthcare-related services, treatments, medications, medical equipment, facilities, and healthcare administration. Increased funding and resources in the healthcare sector drive research and development in immunoglobulins, potentially resulting in the discovery of advanced therapies that enhance market growth. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, it was estimated that between 2021 and 2030, national health spending is going to rise by an average of 5.1% every year, reaching almost $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the increasing healthcare expenditure is driving the growth of the immunoglobulins market.

Major companies operating in the immunoglobulins market report are Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Blood Diagnostic Pharma Inc., Bio Products Laboratory Ltd., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Catalyst Biosciences Inc., Cytiva Corporation, Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

Expansion Of Research And Development Facilities Driving Growth In The Immunoglobulins Market

The launch of new offices and laboratories to boost research and development activities is shaping the immunoglobulins market. Major companies operating in the immunoglobulins sector are focused on opening new laboratories for immunoglobulins to enhance the platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a fully integrated gene therapy firm, has opened offices and laboratories in the Netherlands to develop novel vectorized antibodies for muscular and neurological illnesses. In this laboratory, VectorY creates exclusive and collaborative projects based on a revolutionary AAV platform and antibody-based targeted degradation technology. The company is developing a pipeline of new vectorized antibodies to treat muscle and CNS illnesses, to enhance delivery, durability, and accessibility of specific tissues and cells, to overcome the limits of present therapies.

Innovative Advancements In The Immunoglobulins Market

Major companies operating in the immunoglobulins market are developing innovative products such as intravenous immunoglobulins to meet larger customer bases, more sales, and increase revenue. Intravenous immunoglobulin (IVIG) is a therapeutic product that consists of a concentrated solution of immunoglobulins, which are proteins naturally found in blood plasma. For instance, in February 2021, Pfizer Inc., a US-based pharmaceutical company, announced the U. S. Food and Drug Administration (FDA) approval for PANZYGA. A distinguishing characteristic of this product is its status as the sole intravenous immunoglobulin (IVIg) offering two FDA-approved maintenance dosing alternatives for CIDP, effectively catering to the clinical requirements of patients. Additionally, PANZYGA allows for infusion rates of up to 12 mg/kg/min. This therapy is intended for adult individuals suffering from the uncommon peripheral nerve disorder known as chronic inflammatory demyelinating polyneuropathy (CIDP).

Abbvie Inc. Acquired DJS Antibodies Ltd.

In October 2022, AbbVie Inc., a US-based pharmaceutical company, acquired DJS Antibodies Ltd. for an undisclosed amount. The acquisition is anticipated to bring new capabilities to improve AbbVie's existing antibody research endeavors, bolster its immunology portfolio, and establish a robust presence for broader research initiatives in the thriving bioscience hub located in Oxford, UK. A notable benefit of this acquisition is AbbVie's access to the HEPTAD platform, effectively complementing its robust capabilities in biotherapeutics research. Simultaneously, DJS plans to leverage AbbVie's extensive expertise in drug discovery to continue developing antibody therapeutics and explore novel biological insights, especially in the context of challenging targets such as GPCRs that have proven impervious to biologics-based approaches. DJS Antibodies Ltd. is a UK-based company providing antibody therapeutics.

North America was the largest region in the immunoglobulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunoglobulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The immunoglobins market consists of sales of antibodies, glycoproteins, and antigens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The immunoglobulins market research report is one of a series of new reports from The Business Research Company that provides immunoglobulins market statistics, including immunoglobulins industry global market size, regional shares, competitors with a immunoglobulins market share, detailed immunoglobulins market segments, market trends and opportunities, and any further data you may need to thrive in the immunoglobulins industry. This immunoglobulins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Immunoglobulins Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $19.07 billion
Revenue Forecast In 2033 $28.3 billion
Growth Rate CAGR of 10.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode of Delivery, Subcutaneous Mode of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Baxter International Inc.; CSL Behring LLC; Grifols S. A.; Octapharma AG; China Biologic Products Holdings Inc.; Kedrion SpA; LFB SA; Biotest AG; Sanquin Blood Supply Foundation; ADMA Biologics Inc.; Option Care Health Inc.; Shanghai RAAS Blood Products Co. Ltd.; Antibody Solutions; Blood Diagnostic Pharma Inc.; Bio Products Laboratory Ltd.; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Catalyst Biosciences Inc.; Cytiva Corporation; Immunovant Inc.; Kamada Ltd.; Emergent BioSolutions Inc.; Fresenius Kabi AG; GlaxoSmithKline plc; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Pfizer Inc.; Roche Holding AG; Samsung Bioepis Co. Ltd.; Takeda Pharmaceutical Company Limited; Teva Pharmaceutical Industries Ltd.; Zydus Cadila Healthcare Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Immunoglobulins Market Characteristics

    3. Immunoglobulins Market Trends And Strategies

    4. Immunoglobulins Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Immunoglobulins Market Size and Growth

    5.1. Global Immunoglobulins Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Immunoglobulins Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Immunoglobulins Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Immunoglobulins Market Segmentation

    6.1. Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    IGG

    IGA

    IGM

    IGE

    IGD.

    6.2. Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Intravenous Mode of Delivery

    Subcutaneous Mode of Delivery

    6.3. Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hypogammaglobulinemia

    Chronic Inflammatory demyelinating polyneuropathy (CIDP)

    Immunodeficiency Disease

    Myasthenia Gravis

    Idiopathic thrombocytopenic purpura (ITP)

    Other Applications

    7. Immunoglobulins Market Regional And Country Analysis

    7.1. Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Immunoglobulins Market

    8.1. Asia-Pacific Immunoglobulins Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Immunoglobulins Market

    9.1. China Immunoglobulins Market Overview

    9.2. China Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Immunoglobulins Market

    10.1. India Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Immunoglobulins Market

    11.1. Japan Immunoglobulins Market Overview

    11.2. Japan Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Immunoglobulins Market

    12.1. Australia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Immunoglobulins Market

    13.1. Indonesia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Immunoglobulins Market

    14.1. South Korea Immunoglobulins Market Overview

    14.2. South Korea Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Immunoglobulins Market

    15.1. Western Europe Immunoglobulins Market Overview

    15.2. Western Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Immunoglobulins Market

    16.1. UK Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Immunoglobulins Market

    17.1. Germany Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Immunoglobulins Market

    18.5. France Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Immunoglobulins Market

    19.9. Italy Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Immunoglobulins Market

    20.13. Spain Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Immunoglobulins Market

    21.1. Eastern Europe Immunoglobulins Market Overview

    21.2. Eastern Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Immunoglobulins Market

    22.1. Russia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Immunoglobulins Market

    23.1. North America Immunoglobulins Market Overview

    23.2. North America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Immunoglobulins Market

    24.1. USA Immunoglobulins Market Overview

    24.2. USA Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Immunoglobulins Market

    25.1. Canada Immunoglobulins Market Overview

    25.2. Canada Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Immunoglobulins Market

    26.1. South America Immunoglobulins Market Overview

    26.2. South America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Immunoglobulins Market

    27.1. Brazil Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Immunoglobulins Market

    28.1. Middle East Immunoglobulins Market Overview

    28.2. Middle East Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Immunoglobulins Market

    29.1. Africa Immunoglobulins Market Overview

    29.2. Africa Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Immunoglobulins Market Competitive Landscape And Company Profiles

    30.1. Immunoglobulins Market Competitive Landscape

    30.2. Immunoglobulins Market Company Profiles

    30.2.1. Baxter International Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. CSL Behring LLC

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Grifols S.A.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Octapharma AG

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. China Biologic Products Holdings Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Immunoglobulins Market Competitive Benchmarking

    32. Global Immunoglobulins Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Immunoglobulins Market

    34. Immunoglobulins Market Future Outlook and Potential Analysis

    34.1 Immunoglobulins Market In 2028 - Countries Offering Most New Opportunities

    34.2 Immunoglobulins Market In 2028 - Segments Offering Most New Opportunities

    34.3 Immunoglobulins Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Baxter International Inc. Financial Performance
  • Table 75: CSL Behring LLC Financial Performance
  • Table 76: Grifols S.A. Financial Performance
  • Table 77: Octapharma AG Financial Performance
  • Table 78: China Biologic Products Holdings Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Baxter International Inc. Financial Performance
  • Figure 75: CSL Behring LLC Financial Performance
  • Figure 76: Grifols S.A. Financial Performance
  • Figure 77: Octapharma AG Financial Performance
  • Figure 78: China Biologic Products Holdings Inc. Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Immunity Boosting Food Products Market - By Type Of Product (Herbs & Spices, Nuts & Seeds, Fruits & Vegetables, Dairy-Based Products, Probiotics and Prebiotics, Food Supplements), By Distribution Channel (Store-Based, Non-Store-Based), By Form (Tablets, Capsules, Powder, Liquid, Fresh Food, Chilled/Frozen, Canned, Dried Food), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Viral Vectors And Plasmid DNA Global Market Report 2024 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2024 – By Technique (Competitive Assay, Sandwich Assay, Multiplex Detection Assay), By Application (Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Bi-Specific MAbS Global Market Report 2024 – By Type (Catumaxomab (Removab), Blinatumomab, Duligotumab, Emicizumab, Amivantamab, Faricimab, Teclistamab), By Product Type (In Vivo, In Vitro), By Indication (Cancer, Hemophilia A, Ophthalmic), By End Use (Hospitals, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Immunochemistry Diagnostic Devices And Equipment Global Market Report 2024 – By Product Type (Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables), By Consumables (Antibodies, Antigens, Enzymes, Reagents, Stains, Buffers, Disposables, Other Consumables), By Application (Endocrinology, Oncology, Cardiology, Therapeutic Drug Development & Monitoring, Infectious Disease Testing, Drugs Of Abuse Testing, Other Applications), By End Users (Hospitals And Clinics, Diagnostic Laboratories, Research Labs And Institutes, Biopharmaceutical And Biotechnology Companies, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Orphan Drugs Global Market Report 2024 – By Therapy Area (Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), By Diseases Type (Oncology, Hematology, Neurology, Cardiovascular, Other Disease Types), By Drug Type (Biological, Non-Biological), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Drug Delivery Devices Global Market Report 2024 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Autoimmune Disease Diagnosis Global Market Report 2024 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the immunoglobulins market?

Immunoglobins refer to glycoproteins, often known as antibodies, that are created by plasma cells (white blood cells). They play a crucial role in the immune response by selectively identifying and attaching to specific antigens, such as viruses or bacteria, and assisting in their eradication. For further insights on the in vitro diagnostics (ivd) quality control market, request a sample here

How will the immunoglobulins market drivers and restraints affect the immunoglobulins market dynamics? What forces will shape the immunoglobulins industry going forward?

The immunoglobulins market major growth driver - growing geriatric population fuels demand for immunoglobulins market. For further insights on the in vitro diagnostics (ivd) quality control market, request a sample here

What is the forecast market size or the forecast market value of the immunoglobulins market ?

The immunoglobulins market size has grown strongly in recent years. It will grow from $17.49 billion in 2023 to $19.07 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases. The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $28.3 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness.. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes.. For further insights on the in vitro diagnostics (ivd) quality control market, request a sample here

How is the immunoglobulins market segmented?

The immunoglobulins market is segmentedThe immunoglobulins market covered in this report is segmented –
1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode of Delivery, Subcutaneous Mode of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other ApplicationsFor further insights on the in vitro diagnostics (ivd) quality control market, request a sample here

Which region has the largest share of the immunoglobulins market? What are the other regions covered in the report?

North America was the largest region in the immunoglobulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the in vitro diagnostics (ivd) quality control market, request a sample here.

Who are the major players in the immunoglobulins market?

Major companies operating in the immunoglobulins market report are Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Blood Diagnostic Pharma Inc., Bio Products Laboratory Ltd., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Catalyst Biosciences Inc., Cytiva Corporation, Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Co. Inc., Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited For further insights on the in vitro diagnostics (ivd) quality control market, request a sample here.

What are the key trends in the immunoglobulins market?

Major trend in the immunoglobulins market - expansion of research and development facilities driving growth in the immunoglobulins market. For further insights on the in vitro diagnostics (ivd) quality control market, request a sample here.

What are the major opportunities in the immunoglobulins market? What are the strategies for the immunoglobulins market?

For detailed insights on the major opportunities and strategies in the immunoglobulins market, request a sample here.

How does the immunoglobulins market relate to the overall economy and other similar markets?

For detailed insights on immunoglobulins market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the immunoglobulins industry?

For detailed insights on the mergers and acquisitions in the immunoglobulins industry, request a sample here.

What are the key dynamics influencing the immunoglobulins market growth? SWOT analysis of the immunoglobulins market.

For detailed insights on the key dynamics influencing the immunoglobulins market growth and SWOT analysis of the immunoglobulins industry, request a sample here.